Tianjin Chase Sun Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Tianjin Chase Sun Pharmaceutical Co Ltd working capital to net assets ratio. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Working Capital to Net Assets ratio of 51.8% as of March 2026. Working capital of CN¥4.52 Billion (current assets of CN¥5.74 Billion minus current liabilities of CN¥1.22 Billion) is measured against net assets of CN¥8.72 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 300026 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Working capital to net assets ratio of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2006 to 2024. As of March 2026, the ratio stands at 51.8%, reflecting working capital of CN¥4.52 Billion against net assets of CN¥8.72 Billion CNY. See 300026 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Tianjin Chase Sun Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2006–2024)
Tianjin Chase Sun Pharmaceutical Co Ltd working capital to net assets ratio by year from 2006 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Tianjin Chase Sun Pharmaceutical Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 51.5% | CN¥4.53 Billion | CN¥8.80 Billion | CN¥6.15 Billion | CN¥1.62 Billion | ▼ -6.7 pp |
| 2023 | 58.1% | CN¥5.16 Billion | CN¥8.87 Billion | CN¥6.72 Billion | CN¥1.56 Billion | ▲ +2.5 pp |
| 2022 | 55.6% | CN¥4.71 Billion | CN¥8.46 Billion | CN¥7.39 Billion | CN¥2.68 Billion | ▼ -4.1 pp |
| 2021 | 59.7% | CN¥4.75 Billion | CN¥7.95 Billion | CN¥6.81 Billion | CN¥2.06 Billion | ▲ +14.1 pp |
| 2020 | 45.6% | CN¥3.37 Billion | CN¥7.39 Billion | CN¥5.71 Billion | CN¥2.34 Billion | ▲ +1.9 pp |
| 2019 | 43.8% | CN¥3.09 Billion | CN¥7.07 Billion | CN¥4.33 Billion | CN¥1.23 Billion | ▼ -3.0 pp |
| 2018 | 46.8% | CN¥3.08 Billion | CN¥6.58 Billion | CN¥3.91 Billion | CN¥836.85 Million | ▲ +1.7 pp |
| 2017 | 45.1% | CN¥2.93 Billion | CN¥6.51 Billion | CN¥3.81 Billion | CN¥874.78 Million | ▲ +0.4 pp |
| 2016 | 44.7% | CN¥2.70 Billion | CN¥6.04 Billion | CN¥3.90 Billion | CN¥1.20 Billion | ▼ -2.6 pp |
| 2015 | 47.2% | CN¥2.50 Billion | CN¥5.29 Billion | CN¥3.64 Billion | CN¥1.14 Billion | ▼ -8.7 pp |
| 2014 | 56.0% | CN¥1.32 Billion | CN¥2.36 Billion | CN¥1.98 Billion | CN¥660.65 Million | ▲ +7.0 pp |
| 2013 | 49.0% | CN¥834.02 Million | CN¥1.70 Billion | CN¥1.31 Billion | CN¥474.81 Million | ▲ +2.7 pp |
| 2012 | 46.3% | CN¥641.98 Million | CN¥1.39 Billion | CN¥980.05 Million | CN¥338.07 Million | ▼ -8.8 pp |
| 2011 | 55.0% | CN¥578.01 Million | CN¥1.05 Billion | CN¥845.59 Million | CN¥267.58 Million | ▼ -16.8 pp |
| 2010 | 71.9% | CN¥789.08 Million | CN¥1.10 Billion | CN¥962.17 Million | CN¥173.09 Million | ▼ -12.6 pp |
| 2009 | 84.5% | CN¥782.80 Million | CN¥926.88 Million | CN¥903.18 Million | CN¥120.38 Million | ▲ +72.6 pp |
| 2008 | 11.9% | CN¥14.90 Million | CN¥125.51 Million | CN¥101.92 Million | CN¥87.02 Million | ▲ +23.5 pp |
| 2007 | -11.6% | CN¥-7.13 Million | CN¥61.24 Million | CN¥103.22 Million | CN¥110.35 Million | ▲ +170.2 pp |
| 2006 | -181.8% | CN¥-38.69 Million | CN¥21.28 Million | CN¥45.65 Million | CN¥84.34 Million | — |